BiondVax Pharmaceuticals Ltd.
BVXV · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $27 | $103 | $100 | $262 |
| - Cash | $14 | $54 | $3 | $72 |
| + Debt | $22 | $70 | $21 | $131 |
| Enterprise Value | $34 | $118 | $118 | $320 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $3 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10 | -$27 | $6 | -$93 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$51 | $7 | -$124 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.2 | -36 | 6.15 | -151.98 |
| % Growth | 99.4% | -685.4% | 104% | – |
| Operating Cash Flow | -$7 | -$24 | -$73 | -$77 |
| Capital Expenditures | -$1 | -$0 | -$6 | -$7 |
| Free Cash Flow | -$8 | -$25 | -$79 | -$84 |